vTv Therapeutics (VTVT) Long-Term Debt Issuances (2014 - 2025)

vTv Therapeutics has disclosed Long-Term Debt Issuances across 11 years of filings, most recently posting $392000.0 for Q3 2025.

• In Q3 2025, Long-Term Debt Issuances changed N/A year-over-year to $392000.0; the TTM figure through Dec 2025 stood at $392000.0 (up 105.24% YoY), while the FY2025 annual figure was $392000.0, up 105.24% from the prior year.
• Long-Term Debt Issuances came in at $392000.0 for Q3 2025 at vTv Therapeutics, up from $191000.0 in the prior quarter.
• In the past five years, Long-Term Debt Issuances ranged from a high of $803000.0 in Q3 2021 to a low of $32000.0 in Q4 2022.
• Average Long-Term Debt Issuances over 5 years is $287700.0, with a median of $240000.0 recorded in 2022.
• Year-over-year, Long-Term Debt Issuances tumbled 95.36% in 2021 and jumped 204.76% in 2022.
• Over 5 years, Long-Term Debt Issuances stood at $803000.0 in 2021, then tumbled by 96.01% to $32000.0 in 2022, then rose by 3.12% to $33000.0 in 2023, then soared by 478.79% to $191000.0 in 2024, then surged by 105.24% to $392000.0 in 2025.
• Per Business Quant data, the three most recent Long-Term Debt Issuances figures were $392000.0 in Q3 2025, $191000.0 in Q1 2024, and $33000.0 in Q4 2023.